NCT00803062

Clinical Trial Information


Trial Number: NCT00803062 (ClinicalTrials.gov)
Disease Type:
  • Reproductive System Neoplasm, Female - Cervical Cancer
Trial Title:
A Randomized Phase III Trial of Cisplatin Plus Paclitaxel With and Without NCI-Supplied Bevacizumab (NSC #704865) Versus the Non-platinum Doublet, Topotecan Plus Paclitaxel, With and Without NCI-Supplied Bevacizumab, in Stage IVB, Recurrent or Persistent Carcinoma of the Cervix
Study ID:
GOG-0240
Images are available?:
No
Is this a NCI-MATCH Trial?:
No


Datasets Linked to Trial

Accessibility  |  Disclaimer  |  FOIA  |  HHS Vulnerability Disclosure  |  Privacy & Security

U.S. Department of Health and Human Services  |  National Institutes of Health  |  National Cancer Institute  |  USA.gov

NIH…Turning Discovery Into Health®